Record Quarterly Revenue and Gross Profit Margins
SenesTech reported record quarterly revenue and record gross profit margins, with gross profit margins reaching 65.4%, up from 54.2% a year ago.
Significant Growth in Evolve Product Sales
Sales of the Evolve Rodent Birth Control solution increased by 94% compared to the year-ago quarter and now make up 83% of total quarterly revenue.
Expansion in E-commerce and Retail Channels
E-commerce sales grew by 78% year-over-year and 18% sequentially, now representing more than 50% of quarterly sales. Brick-and-mortar retail sales increased nearly 500% sequentially.
Strong Performance in City and Government Verticals
Government-related sales grew more than 500% from the year-ago quarter, with notable deployments in cities like New York and Chicago.
International Expansion and New Partnerships
SenesTech has agreements with more than 15 countries for Evolve's growth and received a reorder from a Caribbean island.
Successful Capital Raising Efforts
SenesTech raised $6.3 million through a warrant exercise inducement, providing an operating runway through the end of 2027.